Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more) Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Vistagen Therapeutics Inc VTGN

Healthcare Biotechnology
Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company’s product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an... see more

Current News (NDAQ:VTGN)

Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN)

GlobeNewswire 1 hour ago

ROSEN, LEADING INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

Newsfile 2 hours ago

VTGN CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026

ACCESS Newswire 7 hours ago

Pomerantz LLP Issues Reminder to Shareholders in Vistagen Therapeutics, Inc. of Class Action - VTGN

ACCESS Newswire 11 hours ago

VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

ACCESS Newswire 11 hours ago

VTGN UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026

Newsfile 1 day ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTGN

GlobeNewswire 1 day ago

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

GlobeNewswire 1 day ago

VISTAGEN THERAPEUTICS, INC. (NASDAQ:VTGN) DEADLINE ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline

ACCESS Newswire 1 day ago
View More News ››

Opinion & Analysis (NDAQ:VTGN)

VistaGen's fast-acting antidepressant targets multibillion-dollar market

The Life Sciences Report April 27, 2017

VistaGen Therapeutics advances new-generation antidepressant approved by European Patent Office

The Life Sciences Report April 6, 2017

VistaGen licenses stem cell technology to new firm backed by big pharma

The Life Sciences Report December 23, 2016

How markets are rigged against you

Stockhouse Editorial April 14, 2014
View More Opinion ››

Bullboard Posts (NDAQ:VTGN)

VistaGen Therapeutics (NASDAQ : VTGN) Analysis

https://10xalerts.com/vistagen-therapeutics-nasdaq-vtgn-analysis/
Brice978 - April 30, 2024

VSTA - Friday Rundown, Monday Expectations

<< View Post To Watch Video >>
HDavis - December 10, 2021

RE:RE:VTGN - Flying with out any news

Yes a lot of volatility right now. Can be good to avoid this stock for now. Depression stocks will soon be out of favour, when the Covid...
canarsta - January 26, 2021

RE:VTGN - Flying with out any news

Take a look on Twitter, lots of hyping. 
Commoncents - January 25, 2021

VTGN - Flying with out any news

Something is brewing. It is lok down time and it keeps secure the money.
MoneyStock - December 16, 2020

VTGN - Another news out.

VistaGen Announces Korean Intellectual Property Office Decision to Grant PH10 Patent for Treatment of Depression ...
HugeMoney - December 10, 2020
View more Bullboard ››

Osisko Development Corp.

Osisko Development Corp.

Osisko Development Corp. is a continental North American gold development company focused on past-producing mining camps ...
View More »

Podcasts